CALUMET ($CLMT) posted quarterly earnings results for Q1 2026 on Friday, May 8th. The company reported earnings of -$0.64 per share, missing estimates of -$0.57 by $0.07. The company also reported revenue of $1,029,700,000, beating estimates of $976,212,624 by $53,487,376.
You can see Quiver Quantitative's $CLMT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CALUMET Insider Trading Activity
CALUMET insiders have traded $CLMT stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CLMT stock by insiders over the last 6 months:
- DANIEL J SAJKOWSKI sold 2,022 shares for an estimated $0
- JOHN G. BOSS sold 1,011 shares for an estimated $0
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
CALUMET Hedge Fund Activity
We have seen 59 institutional investors add shares of CALUMET stock to their portfolio, and 79 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ADAMS ASSET ADVISORS, LLC removed 1,954,039 shares (-37.9%) from their portfolio in Q1 2026, for an estimated $70,150,000
- TWO SEAS CAPITAL LP added 1,223,691 shares (+21.3%) to their portfolio in Q4 2025, for an estimated $24,314,740
- KNOTT DAVID M JR removed 610,262 shares (-21.6%) from their portfolio in Q4 2025, for an estimated $12,125,905
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 416,275 shares (-74.5%) from their portfolio in Q4 2025, for an estimated $8,271,384
- BANK OF AMERICA CORP /DE/ added 336,751 shares (+93.0%) to their portfolio in Q4 2025, for an estimated $6,691,242
- MORGAN STANLEY added 329,750 shares (+41.8%) to their portfolio in Q4 2025, for an estimated $6,552,132
- WASSERSTEIN DEBT OPPORTUNITIES MANAGEMENT, L.P. removed 243,614 shares (-4.2%) from their portfolio in Q4 2025, for an estimated $4,840,610
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
CALUMET Analyst Ratings
Wall Street analysts have issued reports on $CLMT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 11/10/2025
To track analyst ratings and price targets for CALUMET, check out Quiver Quantitative's $CLMT forecast page.
CALUMET Price Targets
Multiple analysts have issued price targets for $CLMT recently. We have seen 2 analysts offer price targets for $CLMT in the last 6 months, with a median target of $47.0.
Here are some recent targets:
- Amit Dayal from HC Wainwright & Co. set a target price of $60.0 on 03/30/2026
- Neil Mehta from Goldman Sachs set a target price of $34.0 on 03/12/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
